A Gene Sequencing Pioneer Battles Over What It Can Buy

Home » Projects » A Gene Sequencing Pioneer Battles Over What It Can Buy
A Gene Sequencing Pioneer Battles Over What It Can Buy
Is Illumina, a gene-sequencing powerhouse, trying to speed innovation in the field of cancer blood tests or thwart it with an acquisition?